Welcome: Guest | Site Use Options | Register | Login |

Kardia Therapeutics Inc

Kardia Therapeutics Inc

Profile last edited on: 7/24/2018
1709 Dryden Road Suite 910
Houston, TX 77046
  (713) 383-0302
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Kardia Therapeutics, Inc. is a research-stage biotechnology company focused on the development of cardiac regenerative therapies in the areas myocardial infarction and heart failure. Kardia Therapeutics portfolio of technologies utilizes three related approaches: 1) Adult Cardiac Progenitor Cells, 2) Stem Cell Optimization Technologies, and 3) Homing/Growth Factor Therapies. Given the limited capacity of the human heart for self-regeneration, Kardias technologies have the potential to offer significantly improved patient outcomes compared to existing treatments.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Adult Human Progenitor Cells for Cardiac Regeneration
GHRH Treatment of Heart Failure

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920